Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals
Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals
Recruiting · NCT03132311 · Registry updated 2018-07-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals | AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 4 | 2018-07-30 | NCT03132311 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Oswaldo Cruz Foundation | 12 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Instituto Nacional de Infectologia Evandro Chagas | Rio de Janeiro | Brazil | 1 |